If the system is so poor that it must be propped up with off-label and subtherapeautic antibiotics, perhaps its time to revise the system? In an apparent win for pharmaceutical companies, the Food and Drug Administration has recently rescinded a proposed ban on off-label use of cephalosporin drugs in animals raised for food. According to the Wall Street Journal, this last-minute reversal came just five days before the proposed ban would take effect. Has the FDA lost its way? The official mission of the agency states, "The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs," (among other responsibilities like regulating radioactive materials). Despite significant evidence that off-label and widespread agricultural use play a major role in creating antibiotic-resistant bacteria, the FDA has caved under pressure from the very companies selling the drugs. This decision not to ban off-label usage begs the question: What is the point of having a label in the first place?